No CrossRef data available.
Article contents
Myxomatous degeneration of cardiac valves in a fetus with 6q25.1 (TAB2) deletion
Published online by Cambridge University Press: 03 January 2024
Abstract
Myxomatous degeneration of one or more cardiac valves has been reported in trisomy 18, Noonan, Marfan, and Ehlers-Danlos syndromes. 6q25.1 (TAB2) deletion is one of the notable causes for myxomatous degeneration of cardiac valves. Whole exome sequencing must be considered in these subsets of cases for effective prenatal counselling. A 23-week fetus presented with cardiomegaly, redundant myxomatous tricuspid, mitral valve leaflets, thickened pulmonary valve, and bicuspid aortic valves detected to have 6q25.1 (TAB2) deletion was presented with literature review.
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press
References
Thienpont, B, Zhang L, Postma AV, et al. Haploinsufficiency of TAB2 causes congenital heart defects in humans. Am J Hum Genet 2010; 86: 839–849. DOI: 10.1016/j.ajhg.2010.04.011
CrossRefGoogle Scholar
Weiss, K, Applegate, C, Wang, T, Batista, DA. Familial TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of fallot. Am J Med Genet A 2015; 167A: 2702–2706. DOI: 10.1002/ajmg.a.37210.CrossRefGoogle ScholarPubMed
Cheng, A, Dinulos, MBP, Neufeld-Kaiser, W, et al. 6q25.1 (TAB2) microdeletion syndrome: congenital heart defects and cardiomyopathy. Am J Med Genet A 2017; 173: 1848–1857. DOI: 10.1002/ajmg.a.38254.CrossRefGoogle ScholarPubMed
Cheng, A, Neufeld-Kaiser, W, Byers, PH, Liu, YJ. 6q25.1 (TAB2) microdeletion is a risk factor for hypoplastic left heart: a case report that expands the phenotype. BMC Cardiovasc Disord 2020; 20: 137. DOI: 10.1186/s12872-020-01404-5.CrossRefGoogle ScholarPubMed
Woods, E, Marson, I, Coci, E, et al. Expanding the phenotype of TAB2 variants and literature review. Am J Med Genet A 2022; 188: 3331–3342. DOI: 10.1002/ajmg.a.62949.CrossRefGoogle ScholarPubMed
Engwerda, A, Leenders, EKSM, Frentz, B, et al. TAB2 deletions and variants cause a highly recognisable syndrome with mitral valve disease, cardiomyopathy, short stature and hypermobility. Eur J Hum Genet 2021; 29: 1669–1676. DOI: 10.1038/s41431-021-00948-0.CrossRefGoogle Scholar
Deng, Q, Wang, X, Gao, J, et al. Growth restriction and congenital heart disease caused by a novel TAB2mutation: a case report. Exp Ther Med 2023; 25: 258. DOI: 10.3892/etm.2023.11957.CrossRefGoogle ScholarPubMed
Salpietro, V, Ruggieri, M, Mankad, K, et al. A de novo 0.63 Mb 6q25.1 deletion associated with growth failure, congenital heart defect, underdeveloped cerebellar vermis, abnormal cutaneous elasticity and joint laxity. Am J Med Genet A 2015; 167A: 2042–2051. DOI: 10.1002/ajmg.a.37118.CrossRefGoogle Scholar
Gao, WJ, Li, XN. Prenatal ultrasound diagnosis of primary myxomatous degeneration of cardiac valves in a fetus: case report. J Obstet Gynaecol Res 2022; 48: 2620–2623. DOI: 10.1111/jog.15331.CrossRefGoogle Scholar
Karmegaraj supplementary material 1
Karmegaraj supplementary material
File
3.2 MB
Karmegaraj supplementary material 2
Karmegaraj supplementary material
File
1.6 MB
Karmegaraj supplementary material 3
Karmegaraj supplementary material
File
3.2 MB